Ovid Therapeutics Ownership | Who Owns Ovid Therapeutics?
Ovid Therapeutics Ownership Summary
Ovid Therapeutics is owned by 14.29% institutional investors, 15.90% insiders, and 69.81% retail investors. Takeda pharmaceutical is the largest institutional shareholder, holding 10.61% of OVID shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.52% of its assets in Ovid Therapeutics shares.
OVID Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Ovid Therapeutics | 14.29% | 15.90% | 69.81% |
Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Takeda pharmaceutical | 7.53M | 10.61% | $7.01M |
Rubric capital management lp | 5.32M | 7.49% | $4.96M |
Blackrock | 3.99M | 5.65% | $3.07M |
Blackrock funding, inc. /de | 3.93M | 5.54% | $3.67M |
Bvf inc/il | 3.85M | 5.43% | $3.60M |
Madison avenue partners, lp | 3.72M | 5.24% | $3.48M |
Vanguard group | 3.15M | 4.44% | $2.94M |
Siren | 2.85M | 4.02% | $2.66M |
Artal group | 2.50M | 3.54% | $1.92M |
Acadian asset management | 1.85M | 2.61% | $1.73M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Takeda pharmaceutical | 7.53M | 26.40% | $7.01M |
Tls advisors | 680.97K | 1.45% | $636.00K |
Madison avenue partners, lp | 3.72M | 0.37% | $3.48M |
Sio capital management | 1.00M | 0.26% | $933.70K |
Bvf inc/il | 3.85M | 0.12% | $3.60M |
Siren | 2.85M | 0.12% | $2.66M |
Ubs oconnor | 943.42K | 0.07% | $881.15K |
Rubric capital management lp | 5.32M | 0.06% | $4.96M |
Velan capital investment management lp | 70.00K | 0.06% | $65.36K |
Artal group | 2.50M | 0.05% | $1.92M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Driehaus capital management | 1.40M | 0.01% | 1.40M |
Adage capital partners gp | 1.00M | 0.00% | 1.00M |
Sio capital management | 1.00M | 0.26% | 1.00M |
Ubs oconnor | 943.42K | 0.07% | 315.13K |
State street | 1.35M | - | 198.72K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Ecor1 capital | - | - | -6.12M |
Blue owl capital lp | - | - | -864.82K |
Prosight management, lp | - | - | -729.21K |
Fft wealth management | - | - | -489.55K |
Madison avenue partners, lp | 3.72M | 0.37% | -394.15K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Driehaus capital management | 1.40M | 0.01% | 1.40M | $1.08M |
Adage capital partners gp | 1.00M | 0.00% | 1.00M | $933.70K |
Sio capital management | 1.00M | 0.26% | 1.00M | $933.70K |
Velan capital investment management lp | 70.00K | 0.06% | 70.00K | $65.36K |
Susquehanna group, llp | 45.12K | - | 45.12K | $42.13K |
Sold Out
Holder | Change |
---|---|
Nelson, van denburg & campbell wealth management group | -10.00 |
Qube research | -54.00 |
Ica group wealth management | -55.00 |
Capital performance advisors llp | -146.00 |
Metropolitan life insurance co/ny | -977.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2024 | 28 | -63.16% | 10,144,389 | -73.85% | 14 | 0.48% | 13 | -69.05% | 7 | -53.33% |
Sep 30, 2024 | 76 | 2.70% | 38,794,655 | 0.78% | 54 | 1.84% | 42 | 16.67% | 15 | -40.00% |
Jun 30, 2024 | 74 | -8.64% | 38,492,740 | -9.60% | 54 | 1.50% | 36 | -5.26% | 25 | 4.17% |
Mar 31, 2024 | 81 | 5.19% | 42,579,420 | -3.51% | 60 | 1.55% | 38 | -7.32% | 24 | 41.18% |
Dec 31, 2023 | 77 | 20.31% | 44,126,877 | 4.21% | 62 | 1.73% | 41 | 78.26% | 17 | -15.00% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Total Stock Mkt Idx Inv | 1.79M | 2.52% | - |
Vanguard US Total Market Shares ETF | 1.79M | 2.52% | - |
iShares Russell 2000 ETF | 1.64M | 2.31% | -14.19K |
Kennedy Micro Cap | 1.10M | 1.55% | -3.90K |
Vanguard Institutional Extnd Mkt Idx Tr | 819.59K | 1.15% | - |
Fidelity Small Cap Index | 579.52K | 0.82% | -10.85K |
State St Russell Sm/Mid Cp® Indx NL Cl C | 525.80K | 0.74% | - |
State St Russell Sm/Mid Cp® Indx SL Cl I | 525.80K | 0.74% | - |
iShares Russell 2000 Growth ETF | 516.23K | 0.73% | -2.46K |
MEDICAL BioHealth EUR Acc | 503.85K | 0.71% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Feb 26, 2025 | ALEXANDER MARGARET A. | President and COO | Sell | $2.96K |
Feb 26, 2025 | Rona Jeffrey A | CBFO | Sell | $2.19K |
Jan 27, 2025 | ALEXANDER MARGARET A. | President and COO | Buy | $4.97K |
Mar 18, 2024 | LEVIN JEREMY M | CEO | Buy | $50.36K |
Sep 12, 2022 | Tardio Jason | Chief Operating Officer | Sell | $37.29K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q1 | 1 | 2 |
2024 Q4 | - | - |
2024 Q3 | - | - |
2024 Q1 | 1 | - |
2023 Q4 | - | - |
OVID Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools